Daniel Paul Regan, Chief Commercial Officer at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 146 shares at $176.49 ($26K) on 2015-01-05, disclosed to the SEC on 2015-01-07.
Open-market sale of $26k ICPT by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ICPT | SELL | 2014-07-08 | $250 | — | Filing → |
| ICPT | SELL | 2014-03-07 | $8.7M | — | Filing → |